![Von Hippel Lindau (VHL) Clinic at UFHealth » Department of Neurology » College of Medicine » University of Florida Von Hippel Lindau (VHL) Clinic at UFHealth » Department of Neurology » College of Medicine » University of Florida](https://neurology.ufl.edu/wordpress/files/2022/06/vhl-mutation.png)
Von Hippel Lindau (VHL) Clinic at UFHealth » Department of Neurology » College of Medicine » University of Florida
![Cancers | Free Full-Text | The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma? Cancers | Free Full-Text | The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma?](https://www.mdpi.com/cancers/cancers-14-05352/article_deploy/html/images/cancers-14-05352-g002.png)
Cancers | Free Full-Text | The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma?
![A Positive Feedback Loop between Inactive VHL-Triggered Histone Lactylation and PDGFRβ Signaling Drives Clear Cell Renal Cell Carcinoma Progression A Positive Feedback Loop between Inactive VHL-Triggered Histone Lactylation and PDGFRβ Signaling Drives Clear Cell Renal Cell Carcinoma Progression](https://www.ijbs.com/v18/p3470/toc.jpg)
A Positive Feedback Loop between Inactive VHL-Triggered Histone Lactylation and PDGFRβ Signaling Drives Clear Cell Renal Cell Carcinoma Progression
![Molecular pathways and targeted therapies in renal cell carcinoma. VHL:... | Download Scientific Diagram Molecular pathways and targeted therapies in renal cell carcinoma. VHL:... | Download Scientific Diagram](https://www.researchgate.net/profile/Kimryn-Rathmell/publication/7433792/figure/fig2/AS:601714667290638@1520471364289/Molecular-pathways-and-targeted-therapies-in-renal-cell-carcinoma-VHL-Hippel-Lindau.png)
Molecular pathways and targeted therapies in renal cell carcinoma. VHL:... | Download Scientific Diagram
![Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation - ScienceDirect Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0891584918325577-fx1.jpg)
Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation - ScienceDirect
![The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy - ScienceDirect The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S008525381554101X-gr1.jpg)
The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy - ScienceDirect
![Frontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinoma | Future Oncology Frontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinoma | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon.13.258/asset/images/medium/figure2.gif)
Frontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinoma | Future Oncology
![Differential VHL Mutation Patterns in Bilateral Clear Cell RCC Distinguishes Between Independent Primary Tumors and Contralateral Metastatic Disease - Urology Differential VHL Mutation Patterns in Bilateral Clear Cell RCC Distinguishes Between Independent Primary Tumors and Contralateral Metastatic Disease - Urology](https://www.goldjournal.net/cms/asset/598d902c-1236-48f1-bd16-034091f0fae3/gr1.jpg)
Differential VHL Mutation Patterns in Bilateral Clear Cell RCC Distinguishes Between Independent Primary Tumors and Contralateral Metastatic Disease - Urology
![Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL,MET, and CUL2candidate genes | Journal of Medical Genetics Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL,MET, and CUL2candidate genes | Journal of Medical Genetics](https://jmg.bmj.com/content/jmedgenet/37/5/348/F1.large.jpg)
Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL,MET, and CUL2candidate genes | Journal of Medical Genetics
![Figure 1 from Coexistent Non-Hodgkin's Lymphoma and Renal Cell Carcinoma in aPatient with Von Hipple-Lindau Disease: A Case Report | Semantic Scholar Figure 1 from Coexistent Non-Hodgkin's Lymphoma and Renal Cell Carcinoma in aPatient with Von Hipple-Lindau Disease: A Case Report | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/24570b49ee7eedd68da5f6a7cb80b98eaf103428/2-Figure1-1.png)
Figure 1 from Coexistent Non-Hodgkin's Lymphoma and Renal Cell Carcinoma in aPatient with Von Hipple-Lindau Disease: A Case Report | Semantic Scholar
![von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME | Cell Death & Disease von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-019-1507-3/MediaObjects/41419_2019_1507_Fig6_HTML.png)
von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME | Cell Death & Disease
![Frontiers | Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings Frontiers | Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings](https://www.frontiersin.org/files/Articles/514324/fonc-10-00279-HTML/image_m/fonc-10-00279-g001.jpg)
Frontiers | Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings
![Targeted Therapy for Renal Cell Cancer: Current Perspectives - Astrid A. M. van der Veldt - Discovery Medicine Targeted Therapy for Renal Cell Cancer: Current Perspectives - Astrid A. M. van der Veldt - Discovery Medicine](https://www.discoverymedicine.com/Astrid-A-Van-der-Veldt/files/2010/11/discovery_medicine_van-der-veldt_no54_figure_1.png)
Targeted Therapy for Renal Cell Cancer: Current Perspectives - Astrid A. M. van der Veldt - Discovery Medicine
![Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective - ScienceDirect Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419358739-gr1.jpg)